13F filer · CIK 902219 ↗
Wellington Management Group LLP
Reported value
$580.17B
+8.3% on the quarter before
Positions
1,921
254 new · 202 sold out
Top 10
24.9%
of the value
Est. gain
+$56.39B
on stocks held all quarter
Est. return
+12.4%
on those stocks since Q1 2026
Positions as of Jun 30, 2026, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 36% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2026. Striped tiles are options.
Largest buys
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cardinal Health~$2.51BAdded · 0.2% → 0.6%+10,584,119 shares
- Seagate~$2.25BAdded · 0.0% → 0.4%+2,326,538 shares
- Intel~$1.99BAdded · 0.0% → 0.4%+14,244,972 shares
- IBM~$1.77BAdded · 0.0% → 0.3%+6,283,395 shares
- Devon Energy~$1.72BAdded · 0.1% → 0.4%+41,581,435 shares
- Honeywell Aerospace~$1.71BNew · 0.0% → 0.3%+7,716,131 shares
- AMD~$1.37BAdded · 0.3% → 0.9%+2,365,419 shares
- Honeywell Technologies~$1.31BNew · 0.0% → 0.2%+5,845,806 shares
- Micron~$1.30BAdded · 0.2% → 1.0%+1,125,414 shares
- GE Aerospace~$1.25BAdded · 0.2% → 0.4%+3,352,432 shares
Largest sells
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Honeywell Technologies~$3.76BSold out · 0.7% → 0.0%−16,635,316 shares
- Eli Lilly~$2.91BCut · 2.3% → 2.3%−2,428,108 shares
- Meta~$2.51BCut · 1.2% → 0.7%−4,464,151 shares
- Nvidia~$2.36BCut · 4.4% → 4.2%−11,771,482 shares
- Wells Fargo~$2.18BCut · 1.0% → 0.6%−26,423,932 shares
- Cisco~$2.03BCut · 0.5% → 0.3%−17,258,707 shares
- NXP~$1.95BCut · 0.5% → 0.3%−6,924,444 shares
- Microsoft~$1.92BCut · 3.6% → 3.1%−5,138,347 shares
- Coterra Energy Inc~$1.88BSold out · 0.4% → 0.0%−53,570,213 shares
- Amazon~$1.75BCut · 2.4% → 2.3%−7,343,538 shares
Holdings
As of Jun 30, 2026. Changes are in shares against Mar 31, 2026, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −8.8% · price +14.7% | 4.2% | $24.43B | +$3.14B | ||||||||
| BroadcomCOM · shares +3.8% · price +22.0% | 3.4% | $19.48B | +$3.39B | ||||||||
| MicrosoftCOM · shares −9.7% · price +0.8% | 3.1% | $17.76B | +$135.7M | ||||||||
| AppleCOM · shares −8.6% · price +14.0% | 3.0% | $17.20B | +$2.11B | ||||||||
| AlphabetCAP STK CL A · shares −6.8% · price +24.3% | 2.7% | $15.87B | +$3.10B | ||||||||
| Eli LillyCOM · shares −18% · price +30.4% | 2.3% | $13.19B | +$3.08B | ||||||||
| AmazonCOM · shares −12% · price +14.4% | 2.3% | $13.12B | +$1.66B | ||||||||
| Merck & Co.COM · shares +2.3% · price +6.8% | 1.9% | $11.08B | +$692.2M | ||||||||
| MastercardCL A · shares −2.3% · price +2.8% | 1.1% | $6.52B | +$177.0M | ||||||||
| AlphabetCAP STK CL C · shares +25% · price +23.2% | 1.0% | $6.08B | +$915.8M | ||||||||
| MicronCOM · shares +29% · price +241.7% | 1.0% | $5.82B | +$3.20B | ||||||||
| Johnson & JohnsonCOM · shares +13% · price +3.9% | 0.99% | $5.74B | +$191.3M | ||||||||
| AMDCOM · shares +34% · price +185.6% | 0.93% | $5.42B | +$2.63B | ||||||||
| Astrazeneca PlcORD · shares +20% · price −3.5% | 0.92% | $5.36B | −$161.3M | ||||||||
| KLACOM NEW · shares +2.9% · price +104.9% | 0.77% | $4.47B | +$2.23B | ||||||||
| UnitedHealth GroupCOM · shares +5.8% · price +53.6% | 0.76% | $4.44B | +$1.46B | ||||||||
| BlackRockCOM · shares +23% · price −0.0% | 0.74% | $4.32B | −$546,700 | ||||||||
| TeslaCOM · shares +7.5% · price +13.1% | 0.71% | $4.14B | +$447.0M | ||||||||
| MetaCL A · shares −38% · price −1.5% | 0.70% | $4.07B | −$63.9M | ||||||||
| SempraCOM · shares −5.0% · price −4.6% | 0.70% | $4.06B | −$195.4M | ||||||||
| Texas InstrumentsCOM · shares −2.6% · price +53.5% | 0.67% | $3.91B | +$1.36B | ||||||||
| Targa ResourcesCOM · shares −5.8% · price +6.9% | 0.66% | $3.80B | +$246.8M | ||||||||
| Elevance HealthCOM · shares +12% · price +32.1% | 0.61% | $3.56B | +$773.3M | ||||||||
| Cardinal HealthCOM · shares +248% · price +12.4% | 0.61% | $3.53B | +$112.2M | ||||||||
| CVS HealthCOM · shares +50% · price +44.0% | 0.60% | $3.50B | +$713.8M | ||||||||
| Total · 1,921 positions | 100% | $580.17B | +$56.39B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2026 to Q2 2026: 1,603 stocks held throughout, up $56.39B (+12.4%).
- Broadcom+$3.39B+22%
- Micron+$3.20B+242%
- Nvidia+$3.14B+15%
- Alphabet+$3.10B+24%
- Eli Lilly+$3.08B+30%
- ConocoPhillips−$377.5M−21%
- Zoetis−$436.8M−39%
- ExxonMobil−$550.2M−19%
- Netflix−$692.3M−26%
- Northrop Grumman−$853.0M−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 11 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |